checkAd

    Flotek Industries - Fracking Zulieferer - 500 Beiträge pro Seite

    eröffnet am 01.06.11 09:10:07 von
    neuester Beitrag 04.09.19 15:05:14 von
    Beiträge: 42
    ID: 1.166.598
    Aufrufe heute: 0
    Gesamt: 19.027
    Aktive User: 0

    ISIN: US3433894090 · WKN: A3EVCH · Symbol: FTK
    3,7400
     
    USD
    +0,81 %
    +0,0300 USD
    Letzter Kurs 01:04:00 NYSE

    Werte aus der Branche Maschinenbau

    WertpapierKursPerf. %
    1,2500+17,92
    49,77+13,68
    1,6300+12,41
    111,00+11,00
    4,9200+10,07
    WertpapierKursPerf. %
    147,53-12,26
    1,3000-13,91
    1,0900-24,83
    0,5500-71,05
    8,9280-89,08

     Durchsuchen

    Begriffe und/oder Benutzer

     

    Top-Postings

     Ja Nein
      Avatar
      schrieb am 01.06.11 09:10:07
      Beitrag Nr. 1 ()
      bisher eher verlustreich; kommt mit dieser KE wenigstens wieder zu positivem Buchwert...


      Flotek Industries, Inc. Announces $29.5 Million Common Stock Private Placement and $4.5 Million Debt Exchange

      HOUSTON, May 12, 2011 /PRNewswire/ -- Flotek Industries, Inc. (NYSE: FTK) today announced that it has entered into definitive subscription agreements with accredited investors with respect to the private placement of shares of common stock for gross proceeds of approximately $29.5 million. Flotek also announced that it has entered into exchange agreements to issue an aggregate of 559,007 shares of common stock in exchange for $4.5 million in aggregate principal amount of its 5.25% Convertible Senior Notes due 2028.

      Private Placement

      Flotek has entered into subscription agreements to sell 3,665,000 shares of common stock at a price of $8.05 per share. The closing and funding of the private placement is scheduled to occur on or about May 12, 2011.

      Flotek will use the proceeds of the private placement to repay indebtedness under the Company's secured credit facility.

      The shares of common stock have not been registered under the Securities Act of 1933, as amended, and such securities may not be offered or sold in the United States absent a registration statement or exemption from registration.

      Exchange Agreement

      Flotek has entered into exchange agreements with two affiliated holders of $4.5 million in aggregate principal amount of the Company's 5.25% Convertible Senior Notes due 2028 to issue an aggregate of 559,007 shares of common stock in exchange for such notes. The consummation of this exchange is expected to close on or before May 18, 2011. The offer and sale of the shares of common stock in the exchange is being made in reliance on the exemption from registration in Section 3(a)(9) of the Securities Act of 1933, as amended.

      About Flotek Industries, Inc.

      Flotek is a global developer and distributor of a portfolio of innovative oilfield technologies, including specialty chemicals and down-hole drilling and production equipment. It serves major and independent companies in the domestic and international oilfield service industry. Flotek Industries, Inc. is a publicly traded company headquartered in Houston, Texas, and its common shares are traded on the New York Stock Exchange under the ticker symbol "FTK."

      For additional information, please visit Flotek's web site at www.flotekind.com.
      1 Antwort
      Avatar
      schrieb am 11.03.12 12:32:31
      Beitrag Nr. 2 ()
      Antwort auf Beitrag Nr.: 41.586.796 von R-BgO am 01.06.11 09:10:07gute Fortsetzung:

      für 2011 rund 50% EK-Rendite

      ggü. Tief schon wieder verdreifacht
      Avatar
      schrieb am 05.02.14 18:00:54
      Beitrag Nr. 3 ()
      Zahlen kommen nächste Woche
      Avatar
      schrieb am 25.09.14 16:26:12
      Beitrag Nr. 4 ()
      zu 3,5x verkauft...


      leider nur geringe Stückzahl
      10 Antworten
      Avatar
      schrieb am 30.01.15 10:09:16
      Beitrag Nr. 5 ()
      Tuesday, January 27, 2015
      Flotek Industries, Inc. Announces 2014 Results, Provides Financial and Operational Update, Announces Year-End 2014 Conference Call Details

      Flotek reported 2014 Earnings Per Share (fully diluted) of $0.97, an increase of 44.8% from 2013. Fourth quarter fully diluted EPS of $0.29 increased 45.0% from the fourth quarter of 2013 and 11.5% sequentially.

      Flotek announced 2014 annual revenue of $449.2 million, a company record, an increase of 21.0% from 2013 levels. Fourth quarter revenue of $124.5 million was 23.5% above fourth quarter, 2013 revenue and 6.6% greater than third quarter, 2014.

      Flotek introduced its proprietary, patent-pending FracMax™ software in 2014, now with over 75,000 well data points. Based on FracMax data, the use of Flotek's CnF® completion chemistries has added at least $8 billion dollars in aggregate value for operators when compared to those operators that have not adopted CnF chemistry. Recently, the Company announced the debut of FracMax Canada with approximately 10,000 well data points.

      Flotek introduced the Stemulator®, a new axial vibration technology that accelerates drillbit penetration in horizontal wells and debuted its TelePulse™ MWD technology which provides a range of real-time measurements in the lateral section of horizontal wells.

      Flotek repurchased 621,726 shares of its common stock at an average price of $16.74 per share for an aggregate total of approximately $10.4 million in the fourth quarter. Cash generation remains strong with the Company's revolving credit facility balance of approximately $8.5 million on December 31, 2014.

      Flotek unveiled plans for a new 50,000-plus square foot state-of-the-art global research and innovation facility to maximize client collaboration, which is expected to be complete in early 2016.



      HOUSTON, Jan. 27, 2015 -
      Flotek Industries, Inc. ("Flotek" or the "Company") (FTK) today announced results for the three- and twelve-months ended December 31, 2014.

      As reported on Form 10-K filed with the U.S. Securities and Exchange Commission, Flotek reported revenue for the year ended December 31, 2014 of $449.2 million, an increase of $78.1 million, or 21.0%, compared to the year ended December 31, 2013.

      The acceleration in revenue was primarily due to increased sales of the Company's Complex nano-Fluid® suite of completion chemistries as well as strength in downhole technology sales, especially the introduction of the Stemulator® which assists clients with increasing the rate of penetration during horizontal drilling.


      Income from Operations for the year ended December 31, 2014 was $80.9 million, an increase of 37.7%, compared to $58.7 million in the same period of 2013.

      The company recorded an income tax provision of $25.3 million, yielding an effective tax rate of 32.0% for the year ended December 31, 2014 compared to an income tax provision of $20.8 million yielding an effective tax rate of 36.5% in the prior corresponding period.

      For the year ended December 31, 2014, the Company reported net income of $53.6 million or $0.97 per share (fully diluted) an increase of $.30, or 44.8%, compared to net income of $36.2 million or $0.67 per share (fully diluted) for the year ended December 31, 2013.

      Earnings Before Interest, Taxes, Depreciation and Amortization, or EBITDA (a non-GAAP measure of financial performance), for the year ended December 31, 2014 was $98.3 million, an increase of $24.2 million, or 32.6%, compared to $74.2 million for the year ended December 31, 2013.

      For the year ended December 31, 2014, Flotek's non-cash share-based compensation expense was approximately $10.5 million. For the year ended December 31, 2013, non-cash share-based compensation was $10.9 million.

      A presentation of non-cash share based compensation and a reconciliation of GAAP net income to EBITDA can be found at the conclusion of this release.


      Consolidated gross margin increased to 40.7% for the year ended December 31, 2014 from 39.8% from the corresponding 2013 period.

      "2014 was a special year for Flotek and its shareholders as the Flotek team continued to set new records in nearly every performance metric," said John Chisholm, Flotek Chairman, President and Chief Executive Officer. "The hard work and dedication of each member of the Flotek team contributed to record revenue and operating income as well as new operating milestones that continue to better position Flotek for the future."

      "The introduction of our FracMax™ analytical software provides Flotek with a unique competitive advantage that has not previously been available in our industry," added Chisholm. "In fact, based on the over 75,000 wells available in FracMax with at least one-year of production data, we can confidently indicate that Flotek's CnF® completion chemistries have created over $8 billion in additional value for our exploration and production clients in the form of increased production when compared to wells not using CnF chemistry."

      "There is little doubt that 2015 will present a plethora of challenges for the Flotek team," added Chisholm. "However, we enter this period of uncertainty and volatility with unprecedented financial strength and flexibility, a team that understands how to execute in challenging environments, and a stable of differentiating technologies that will assist our clients in enhancing their exploration and production efforts. Together, we believe these tenets place Flotek in a position of relative strength as we navigate these uncharted waters."

      A complete review of the Company's year-end financial position can be found in the Company's annual report filed with the U.S. Securities and Exchange Commission this afternoon.



      Fourth Quarter 2014 Results
      For the three months ended December 31, 2014, Flotek posted revenue of $124.5 million, an increase of $23.7 million, or 23.5%, compared to $100.8 million in the same period of 2013. Revenue increased $7.7 million, or 6.6%, compared to third quarter, 2014.

      Income from operations for the three months ended December 31, 2014 was $23.6 million, an increase of $6.0 million, or 34.2%, compared to $17.6 million in the same period of 2013. Income from Operations increased $2.7 million, or 13.1%, compared to third quarter, 2014.
      In the fourth quarter, 2014 Flotek recorded income tax expense of $6.9 million, compared to $6.2 million in the fourth quarter of 2013.

      On a GAAP basis, Flotek posted Earnings per Share (fully diluted) for the three months ended December 31, 2014 of $.29, an increase of $.09, or 45.0%, compared to Earnings per Share (fully diluted) of $.20 for the three months ended December 31, 2013. Earnings per Share (fully diluted) increased $.03, or 11.5%, compared to third quarter, 2014.

      Earnings Before Interest, Taxes, Depreciation and Amortization, or EBITDA, for the three months ended December 31, 2014 was $28.1 million, an increase of $6.1 million, or 28.0%, compared to $21.9 million for the three months ended December 31, 2013. EBITDA increased $2.8 million, or 11.2%, compared to third quarter, 2014.

      For the quarter ended December 31, 2014, Flotek's non-cash share-based compensation expense was approximately $3.0 million. For the quarter ended December 31, 2013, non-cash share-based compensation was $2.2 million.

      Consolidated gross margins for the three months ended December 31, 2014 were 40.9% compared to 39.5% in the same period of 2013 and 39.5% in the third quarter 2014.


      "Even as the swoon in energy commodity prices began to impact activity during the quarter, Flotek continued to show solid growth during the last three months of 2014," added Chisholm. "Notwithstanding moderated activity and the Thanksgiving and Christmas holidays, CnF usage continued to lead our growth as pressure pumping companies and exploration and production concerns continued to better understand the positive impact Flotek's completion chemistries have on production and ultimate economics of a well. We believe the ability to maximize economics of a well becomes even more important in a lower-price commodity environment which should provide relative benefits to Flotek."

      A summary income statement reflecting fourth quarter results can be found at the conclusion of this release.


      Full Year 2014 – Segment Results
      Energy Chemical Technologies revenue of $268.8 million for the year ended December 31, 2014 increased $67.8 million, or 33.8%, from year ago levels, primarily due to the increased sales of stimulation chemical additives, largely the result of the introduction of the Company's proprietary, patent-pending FracMax software which statistically demonstrates the positive production and economic impact of using Flotek's CnF chemistries in unconventional well completions. FracMax has led to a record number of new validation projects and accelerated commercial acceptance of the Company's CnF completion chemistries. Segment gross margin for the year ended December 31, 2014 was essentially unchanged at 43.9% from a year ago. Income from operations of $84.8 million for the year ended December 31, 2014 increased $19.5 million, or 29.7%, from year ago levels.

      Drilling Technologies revenue of $113.3 million for the year ended December 31, 2014 increased $0.9 million, or 0.8% from the full year 2013 primarily due to an increase in actuated tool rentals. Gross margin increased to 40.3% compared to 38.4% from year ago levels. This was primarily due to increased material margins on actuated tool rentals as a direct result of decreases in repair cost and direct expense controls initiated during 2014. Income from operations of $19.0 million for the year ended December 31, 2014 increased $0.7 million, or 3.9%, from year ago levels.

      Revenue for the Production Technologies segment of $16.0 million for the year ended December 31, 2014 revenue increased by $1.2 million, or 8.1% from the prior corresponding period as sales of Petrovalves and lifting units rose by $4.6 million, or 152.9% in 2014. Offsetting those revenue increases was a decrease in equipment sales and related services of $3.5 million, or 31.1% in coal-bed methane related business. Segment gross margin increased to 40.9% compared to 35.0% for the year ended December 31, 2013, primarily due to the higher margins associated with the international valve sales and improvement in margins on pump equipment. Income from operations of $3.2 million for the year ended December 31, 2014 increased $0.2 million, or 6.1%, from year ago levels.

      Consumer and Industrial Chemical Technologies ("CICT") revenue of $51.1 million for the year ended December 31, 2014 increased $8.2 million or 19.0%, from the prior corresponding period, as the segment was created in the second quarter of 2013 upon the acquisition of Florida Chemical. Segment gross margin increased to 25.2% for the year ended December 31, 2014 compared to 24.8% in 2013. Income from operations of $6.6 million for the year ended December 31, 2014 increased $0.3 million, or 4.8%, from year ago levels.


      Fourth Quarter 2014 – Segment Results
      Energy Chemical Technologies segment reported revenue of $75.6 million for the three months ended December 31, 2014. Energy Chemical Technologies revenue for the three months ended December 31, 2014 increased $18.7 million, or 32.9%, relative to the comparable period of 2013. Segment revenue for the three months ended December 31, 2014 increased $7.4 million, or 10.9%, compared to third quarter, 2014.

      Income from operations for the Energy Chemical Technologies segment of $24.2 million increased $4.1 million, or 20.2%, for the three months ended December 31, 2014 compared to the same period of 2013. Income from operations for the segment increased $4.3 million, or 21.4%, compared to third quarter, 2014.

      Drilling Technologies reported revenue of $31.2 million for the three months ended December 31, 2014, an increase $5.1 million, or 19.5%, relative to the same period in 2013. Segment revenue for the three months ended December 31, 2014 increased $1.3 million, or 4.4%, compared to third quarter, 2014.

      Drilling Technologies income from operations of $5.9 million for the three months ended December 31, 2014 increased by $3.2 million, or 112.8%, as compared to the same period of 2013. Income from operations for the segment increased $0.4 million, or 7.1%, compared to the third quarter, 2014.

      Revenue for the Production Technologies segment of $5.9 million for the three months ended December 31, 2014 increased by $3.1 million, or 107.5%, from the same period in 2013. Segment revenue for the three months ended December 31, 2014 increased $1.0 million, or 19.5%, compared to third quarter, 2014.

      Production Technologies income from operations of $1.3 million increased by $1.0 million, or 280.7%, for the three months ended December 31, 2014 compared to the same period in 2013. Income from operations for the segment decreased $0.3 million, or 16.6%, compared to third quarter, 2014.

      CICT revenue of $11.7 million for the three months ended December 31, 2014 decreased $3.2 million, or 21.5%, compared to the same period in 2013. Segment revenue for the three months ended December 31, 2014 decreased $2.0 million, or 14.4%, compared to third quarter, 2014.

      Income from operations for the CICT segment of $1.5 million decreased $0.1 million, or 7.4%, for the three months ended December 31, 2014 compared to the same period of 2013. Income from operations for the segment decreased $0.3 million, or 15.2%, compared to third quarter, 2014.


      Full Year 2014 - Financial Metrics
      Accounts receivable, net of the allowance for doubtful accounts, at December 31, 2014 were $78.6 million, compared to $65.0 million December 31, 2013. The Company's allowance for doubtful accounts was 1.1% of accounts receivable at December 31, 2014.

      Depreciation and amortization expense not included in gross margin, for the year ended December 31, 2014 increased by $2.5 million, or 33.9% from the prior corresponding period. This increase was primarily attributable to the depreciation and amortization of assets recognized as part of the acquisition of Florida Chemical in the second quarter of 2013 and the acquisition of EOGA in the first quarter of 2014.

      Interest expense decreased $0.5 million for the year ended December 31, 2014 compared to the prior corresponding period.

      During the fourth quarter Flotek repurchased 621,726 shares of its common stock at an average price of $16.74 per share for an aggregate total of approximately $10.4 million. The repurchase was made pursuant to a $25 million share repurchase program authorized by the Company's Board of Directors in November, 2012.

      "Not only did Flotek post record growth in 2014, it did so while continuing to improve its financial position, especially its balance sheet," added Chisholm. "We continue to generate significant cash and, even with our meaningful share repurchases in December, remain well positioned to prudently allocate capital as opportunities arise. We continue to be disciplined in our approach to reinvesting capital, looking for opportunities that will continue our commitment to strategic investments that stand in support of Flotek's goals of remaining an energy technology leader as well as adding value for our shareholders. We will continue to consider all opportunities that we believe create durable value across the pricing cycle."

      "The power of Flotek's cash generation ability is persuasively demonstrated in our recent decision to repurchase Flotek stock," opined Chisholm. "While we repurchased $10.4 million of Flotek shares in December, we ended the year with a balance on our revolving credit facility of about $8.5 million, a clear sign that we continued, even as the market began to slow, to generate significant cash from operations."

      Flotek also continued to improve productivity during 2014. Revenue generation per employee increased by approximately 12% compared to year-ago levels and operating income per employee increased by nearly 22%.

      "The success of Flotek is a direct result of the people of Flotek and we are fortunate to have assembled one of the most productive teams in our business," said Chisholm. "While we understand the challenges ahead, I remain optimistic about Flotek's future as I am confident my colleagues will embrace the challenges – as they have in the past – and find ways to maximize value for all our stakeholders, remaining a top-performing energy technology company at every point in the cycle."


      Project Updates
      The introduction of FracMax, Flotek's proprietary, patent-pending analytical software, has provided the Company with a dynamic tool to demonstrate the efficacy of the Company's CnF completion chemistries. As a result of FracMax, the Company has converted approximately 20 exploration companies from validation clients to ongoing commercial users. Currently, the Company has an additional 15-20 companies in the process of conducting or planning validations. Data provided by FracMax Analytics indicates that, of the wells cataloged, CnF completion chemistries have been used by 234 unique operators.

      "Our FracMax software technology provides conclusive evidence that our Complex nano-Fluid suite of completion chemistries provides compelling economic benefits to production companies," added Chisholm. "Regardless of the position of the cycle, the economic value of Flotek's completion chemistries is compelling given the empirical data available through FracMax, now a hallmark of our growth strategy in the coming year and beyond. We are confident as more producers become aware of the economic benefit of CnF chemistries, the value creation impact will accelerate meaningfully."

      Flotek also announced the introduction of FracMax Canada with approximately 10,000 wells. The Company's penetration into Canada continues to accelerate with nearly every Canadian-based pressure pumping company now pumping CnF completion chemistries in a number of projects.

      "We believe FracMax, in just its first year, is quickly being recognized as the premier analytical tool in determining optimal completion methods," added Chisholm. "Our ability to run virtually limitless production comparisons through our FracMax Analytics subsidiary is not only helping our clients better understand the compelling benefit of using CnF chemistry in the completion process but also assisting clients in developing a better understanding of completion best practices through an analysis of data derived from the FracMax database."

      Recently, Flotek announced plans to begin construction of a new 50,000-plus square foot global research and innovation headquarters in Houston. The state-of-the-art facility will bring all of Flotek's scientists under one roof and provide unprecedented access to the Company's theoretical and applied research to Flotek's clients. The facility is expected to be completed early in 2016.

      The Company continues to work with a major operator in the Bakken to validate the efficacy of the use of CnF in unconventional formation recompletions. Due to weather and mechanical issues, completion of the project is taking longer than initially expected. While early indications suggest Flotek's chemistry is performing as expected, formal results are now expected later in the first quarter.

      Flotek also continues the process of validation of its MicroSolutions chemistry for use with Saudi Aramco. Laboratory work is being completed and the initial well testing is imminent. The Company expects to discuss the results of the trial as soon as practical.

      Also on the international front, Flotek initiated land preparation on its chemistry blending facility in Oman through Flotek Gulf, LLC, a joint venture with Gulf Energy, an Omani-based integrated oilfield service company. Permitting and construction should begin in the coming weeks.

      "We remain very constructive on our international chemistry business," added Chisholm. "While commodity prices will have an impact on activity around the globe, Middle Eastern markets do not appear to have reacted as severely as domestic markets. Discussions with our partners and, in turn, their customers suggest a plethora of opportunities to grow our business in the coming months."

      In Drilling Technologies, Flotek continues to introduce new technologies in the market to address the needs of more complex horizontal and directional drilling projects. During 2014, Flotek continued to improve its Stemulator offering, the Company's axial vibration technology that improves the rate of penetration in horizontal drilling. The company now has approximately 100 unique tools to be deployed across basins.

      In addition, during the fourth quarter, Flotek began commercial testing of TelePulse™, its Measurement While Drilling ("MWD") tool for use in the lateral section of horizontal wells. The Company expects TelePulse to be fully commercial in the first-half of 2015. The Company's core Teledrift® MWD technology continues to be the standard-bearer in vertical applications, experiencing meaningful growth – including key international adoptions - throughout 2014.

      "We are very pleased with the performance of our Drilling Technologies segment over the past twelve months," added Chisholm. "Not only did we experience solid margin growth over the year, the fourth quarter provided the highest quarterly gross margins in 2014. While we are cognizant of the challenges ahead, we believe the commercialization of the Stemulator and TelePulse do provide new added-value technologies that will somewhat offset an expectation of reduced demand for commoditized tools as the rig count moderates. We will be especially vigilant in watching drilling technologies costs during periods of uncertainty and volatility."

      The Company's Production Technologies segment continues its successful retooling which is beginning to yield results. Flotek saw steady growth in rod pump and hydraulic lifting sales during the year as well as international sales of Petrovalve. During the second-half of the year, the Company opened its Denver office which will serve as the headquarters of the Production Technologies segment as well as a service office in Vernal, Utah.

      "We believe Production Technologies is well positioned and could provide positive surprises in the coming year," said Chisholm. "With the market downturn, we will continue to look for strategic opportunities that will provide technological advantages at value prices. Our focus on niche technologies and superior service should provide Flotek with opportunities to grow this business even in the current market environment and emerge as a significant player when the market cycle accelerates."

      "2014 was a transformational year for Flotek, proving that innovative technologies do make a difference in the oil patch and that a focus on detail and strong financial position do serve to create value for our stakeholders," added Chisholm. "While we know we face significant headwinds and uncertainty in the weeks and months ahead, our balance sheet and portfolio of proprietary, added-value technologies will provide, we believe, remarkable opportunities to add value for our clients and, in turn, our shareholders. We will be vigilant in rationalizing expense in this market environment but, at the same time, will be opportunistic in our quest to create value – both intrinsically and, where appropriate, extrinsically – through a focus on the right technologies with the right people in our pursuit to make certain we remain at the forefront of creating positive economic impact for our clients."

      Trading Spotlight

      Anzeige
      Was die Börsencommunity nach Ostern auf keinen Fall verpassen willmehr zur Aktie »
      Avatar
      schrieb am 30.01.15 22:33:06
      Beitrag Nr. 6 ()
      Wer sind die wesentlichen Konkurrenten? Schlumberger?
      3 Antworten
      Avatar
      schrieb am 30.01.15 23:05:22
      Beitrag Nr. 7 ()
      Antwort auf Beitrag Nr.: 48.940.007 von DJHLS am 30.01.15 22:33:06so wie ich das verstehe, beliefern sie Schlumberger, Halliburton &Co.
      (siehe Seiten 5,6 & 17 von http://www.flotekind.com/Assets/20141203-cowen.pdf);

      zum Wettbewerb finde ich nichts, nicht mal in den beiden 10k von heute und letztem Jahr steht ein konkreter Name, nur allgemeines blabla
      2 Antworten
      Avatar
      schrieb am 30.01.15 23:15:37
      Beitrag Nr. 8 ()
      Antwort auf Beitrag Nr.: 47.875.667 von R-BgO am 25.09.14 16:26:12
      Zitat von R-BgO: zu 3,5x verkauft...


      leider nur geringe Stückzahl



      ach ja, seit heute wieder drin mit einer halben Position zu $16,21

      auf die habe ich einen Jan2016 short-call mit strike 17,50 verkauft für $2,05


      über die gleiche Stückzahl habe ich Jan2016 einen short-put mit strike 15$ verkauft zu $2,10;


      damit profitiere tendenziell davon, wenn wenig passiert:

      pro Kontrakt habe ich eingesetztes Kapital von 1.621+1.500-205-210 = $2.706

      wenn der Kurs am Ende über 17,50 steht, dann bleiben 1.500+1.750 = 3.250 übrig => Rendite 20,1%
      wenn der Kurs am Ende unter 15,00 steht, dann habe ich einen Durchschnittseinstand von 2.706/200 = $13,53 (also 16,5% Rabatt auf den heutigen Kurs)

      und dazwischen ist es auch ok
      9 Antworten
      Avatar
      schrieb am 31.01.15 13:18:06
      Beitrag Nr. 9 ()
      Antwort auf Beitrag Nr.: 48.940.184 von R-BgO am 30.01.15 23:05:22
      Zitat von R-BgO: so wie ich das verstehe, beliefern sie Schlumberger, Halliburton &Co.
      (siehe Seiten 5,6 & 17 von http://www.flotekind.com/Assets/20141203-cowen.pdf);

      zum Wettbewerb finde ich nichts, nicht mal in den beiden 10k von heute und letztem Jahr steht ein konkreter Name, nur allgemeines blabla


      Hmm. Was können die, was Schlumbeerger und Halliburton nicht können? Wenn Flotek quasi ein Monopolist wäre und SLB, HAL und andere auf die Produkte von Flotek angewiesen wären, müßte das für gesicherte Margen sorgen.
      1 Antwort
      Avatar
      schrieb am 23.02.15 10:14:20
      Beitrag Nr. 10 ()
      Antwort auf Beitrag Nr.: 48.942.506 von DJHLS am 31.01.15 13:18:06Sie geben sich zumindest so, als ob Ihre Chemikalien "proprietary" und "patented" wären;

      außerdem scheint die Kombi mit der "Frac-Max" Software was zu bringen: sie verwenden "operator-published-data" von inzwischen 75.000 wells, anhand derer sie die wirtschaftlichen Vorteile ihrer Produkte "nachweisen" können.

      Der Call hier ist von letzter Woche und gibt ein paar Einblicke: http://www.oilandgas360.com/tosc-webcast/ftk/
      Avatar
      schrieb am 23.02.15 15:24:48
      Beitrag Nr. 11 ()
      FTK Announces Introduction of CnF® Chemistry Applications for Well Remediation and Restimulation
      HOUSTON, February 23, 2015 -

      Flotek Industries, Inc. (NYSE: FTK - News) announced today that it will introduce new and unique Complex nano-Fluid® chemistries that will address the growing market for remediation and restimulation of existing, unconventional wells.

      “As the commodity price environment changes so too will the need of producers to reconsider alternatives to drilling new wells to maintain and grow production in a more efficient manner,” said John Chisholm, Flotek’s Chairman, President and Chief Executive Officer of Flotek. “Our data suggest that a remediation or restimulation treatment of a well using a tailored CnF chemistry design can reinvigorate production by 30-70% and, in some cases, return the well to its original production profile. More important, it can do so at a fraction of the cost of drilling and completing a new well. We are excited about our initial work and look forward to introducing this new CnF application to our clients and others in the coming weeks and months.”

      While the design of a remediation or restimulation program will vary, it is unlikely necessary to involve a total recompletion or refracturing of an existing producing well. Instead, it will involve a basic “pump and pressure treatment” utilizing a coil tubing unit, using CnF in a fluid system that will penetrate the existing fractures in the formation and mitigate wellbore blockages caused by paraffins, asphaltenes, and other “clogging particles”.

      “Through remediation and restimulation we are leveraging the solvent properties of d-limonene in our CnF chemistry with a retreatment using, in most cases, a coil tubing unit and, as a result, gain the benefits provided by CnF chemistry in a primary completion,” said Steve Marinello, PhD, Flotek’s Director of Applied CnF Technology. “The impact for the operator is not only increased production at a significantly reduced cost but also the likelihood of an increase in proved reserves from new reservoir volume contacted and increased value for wells where the remediation and restimulation treatments have been effective.”

      Flotek plans a full-scale launch of its remediation chemistry in early March at several professional conferences and through targeted marketing efforts.

      “With concerns over capital spending causing severe constraints on new drilling and, as a result, production growth for many of our clients, we believe remediation and restimulation with CnF is a compelling answer to the challenge of reducing costs and growing production at the same time,” added Chisholm. “With the data available to us through our FracMax™ database and proprietary validations, as well as the use of our advanced reservoir modelling and historical matching capabilities through our SiteLark subsidiary we are not only able to show the efficacy of the CnF remediation program we can also assist our clients in identifying existing wells that should have significant impact on production growth after remediation and restimulation. We believe the combination of FracMax and CnF remediation will add significant value to our clients’ production profiles.”
      Avatar
      schrieb am 15.04.15 09:52:01
      Beitrag Nr. 12 ()
      Flotek Industries and Solazyme Announce Strategic Agreements
      ... to Develop and Market Advanced Drilling Fluid Technologies and Expand Marketing of Encapso™ in the Middle East

      HOUSTON and SOUTH SAN FRANCISCO – April 14, 2015 /PRNewswire/ --


      Flotek Industries, Inc. (NYSE:FTK) (“Flotek”) and Solazyme, Inc. (NASDAQ: SZYM) (“Solazyme”) today announced the companies and certain subsidiaries have entered into agreements to globally commercialize Flocapso™, an innovative, advanced drilling fluid additive. In addition, Flotek will market Solazyme’s Encapso™ lubricant - the first commercially available, biodegradable encapsulated lubricant for drilling fluids – in certain Middle Eastern markets.

      Under the Joint Product Development and Marketing Agreement (the “Joint Agreement”), Flotek and Solazyme will commercialize and market Flocapso, a proprietary formulation combining Flotek’s patented Complex nano-Fluid® chemistries with Solazyme’s proprietary Encapso technology to create an environmentally-conscious, highly effective drilling fluid additive focused on better lubricity and greater stabilization for drilling programs worldwide. Laboratory and commercial testing indicate that the Flocapso additive will allow the use of water-based fluids in wells that previously required more expensive and invasive oil-based products, providing an environmentally superior, more efficient solution to drilling challenges around the globe.

      “Our partnership with Solazyme is another important step in Flotek’s quest to identify and partner with innovative and efficacious technologies that advance oilfield chemistry for the benefit of our clients,” said John Chisholm, Chairman, President and Chief Executive Officer of Flotek. “Solazyme’s development of Encapso and its rapid recognition as a break-through lubricant in drilling applications is testament to Solazyme’s world-class research team. We are delighted to have an opportunity to work with the Solazyme team as we continue our focus on developing the best chemistry solutions for the oilfield.”

      “We are excited to add Flotek as a strategic partner as we continue to focus on broadening the market and customer base for Encapso,” said Solazyme Chief Executive Officer Jonathan Wolfson. “As a leading, global technology company with a focus on oilfield chemistry, Flotek brings new opportunities to expand sales of Encapso in the Middle East, as well as to commercialize and jointly market Flocapso, a unique and high performance product that provides a large global sales opportunity to satisfy an unmet need through the combination of superior technologies. The new Flocapso drilling solution is designed to provide significant advantages in lubricity and stabilization and a much cleaner environmental footprint.”

      Under the Joint Agreement, Flotek and Solazyme will continue the development of the Flocapso chemistries and work cooperatively to market Flocapso worldwide. The companies are currently in an active validation project with a large national oil company in the Middle East and are pursuing commercial applications in both domestic and international markets.

      Winner of the Presidential Green Chemistry Challenge Award, Solazyme launched Encapso in early 2014. With its unique, targeted lubricant delivery system, Encapso has shown to increase the rate of penetration, decrease drag and reduce both rotational torque and friction in a variety of vertical and horizontal drilling applications. This can lead to lower drilling costs, reduced non-productive time, and accelerated operations. Developed from Solazyme’s proprietary technology platform, Encapso is non-toxic and biodegradable.

      Flotek’s Complex nano-Fluid, or CnF®, chemistries are a series of proprietary, patented chemistries designed to enhance performance in oil and natural gas wells, including increased productivity through improved production rates and higher ultimate recoverability. The proprietary combination of citrus-based solvents and surfactants which are combined to create a nano-molecular chemistry provide unique benefits in the drilling process.

      “Last year we acquired certain intellectual property related to the use of CnF in drilling fluid applications from Tony Rea, a drilling fluid technology pioneer, which led to discussions and chemical trials with Solazyme,” said Chisholm. “As a result of Tony’s work showing the efficacy of using CnF to improve drilling results and the combination of Solazyme’s Encapso, we developed Flocapso, a drilling fluid additive that we believe will provide significant improvements to drilling efficiency and effectiveness around the globe.”

      In addition, the companies have entered into a Strategic Alliance Agreement (the “Agreement”) whereby Solazyme has granted Flotek exclusive distribution rights to sell and market Encapso as a drilling fluid lubricant in certain territories in the Middle East. In exchange, Flotek has agreed to certain minimum purchases of Encapso from Solazyme in the initial year of the Agreement.

      “We are excited about the opportunity to work closely with Solazyme to promote the use of the Encapso lubricant in the Middle East and beyond,” added Chisholm. “Our work with the Solazyme team and Encapso gives us great confidence that this game-changing technology has broad applications in many markets, especially those in which we have established relationships. Combined with our jointly developed Flocapso product, we believe this Agreement creates a meaningful advantage for Flotek as we continue to develop Middle Eastern markets.”

      “Flotek’s expertise, infrastructure and established and emerging relationships in the Middle East make them an outstanding partner for Solazyme and Encapso,” added Wolfson. “Combined with our relationships and product support team, we believe the Flotek partnership provides an excellent opportunity to accelerate market adoption of Encapso, both through certain of Flotek’s distribution and sales channels in the Middle East, and through sales of the combined Flocapso drilling fluid additive worldwide.”
      Avatar
      schrieb am 26.04.15 10:08:20
      Beitrag Nr. 13 ()
      Flotek ist ein interessanter Wert. Allerdings waren die letzten Quartalszahlen grausam. Scheint mir ein klassischer play auf den turnaround der Ölpreise.
      7 Antworten
      Avatar
      schrieb am 05.10.15 13:24:34
      Beitrag Nr. 14 ()
      Flotek Industries Announces Technical Partnership with Ely & Associates,
      Update on Third Quarter Operating Activity and Third Quarter Reporting Schedule


      HOUSTON, October 5, 2015 /PRNewswire/ --

      Flotek Industries, Inc. (NYSE: FTK - News) (“Flotek” or the “Company”) this morning announced a technical partnership with Ely & Associates (“Ely”), a leading international stimulation and completion consulting firm, under which Flotek and Ely will provide Flotek CnF® completion chemistry clients a suite of stimulation and completion consulting services to further extend Flotek’s reach as the leading North American completion chemistry and consulting services concern.

      Through the partnership, Flotek will package Ely’s world-class reservoir stimulation and completion consulting services with the Company’s CnF® customized completion chemistries for those clients that purchase CnF® chemistries directly through The Flotek Store™.

      Ely and Associates, founded by John Ely and three partners in 1991, is a leading global reservoir completion consulting firm. With combined experience of over 800 years, Ely has assembled a unique group of engineering professionals specializing in the stimulation o f oil and gas wells. Today, the group has a team of 85 engineers dedicated to implementing the very best the industry has to offer in fracturing technology, well completions, stimulation fluid design, and reservoir analysis. Ely and Associates has provided quality assurance services on over 60,000 unconventional completions in North America, with nearly every major exploration and production company as well as most completion services company.

      While attending Oklahoma State University, Mr. Ely joined Halliburton as a technician in their analytical group in 1965. Upon graduating from OSU in 1968 with a degree in chemistry, he returned to Halliburton and served as a chemist and senior chemist in fracturing research. In 1973 he moved into international operations where he served in roles of growing responsibility around the globe until he returned to the U.S., becoming technical advisor to Halliburton’s international operations in 1977. In 1985, Mr. Ely joined S.A. Holditch and Associates as Vice President of Stimulation Technology where he was instrumental in the firm’s stimulation chemistry research, much of the work under the auspices of the Gas Research Institute. Mr. Ely holds several patents and has numerous publications, including a book titled “Stimulation Treatment Handbook / An Engineer’s Guide to Quality Control”. He is also a contributing author to the S.P.E. monograph on hydraulic fracturing, writing the chapter on hydraulic fracturing fluids and fracture fluid selection. He is a member of the American Chemical Society, The Society of Petroleum Engineers, and is a fellow of the American Institute of Chemistry.

      “There are very few completion engineers and oilfield chemists that do not know and have not been influenced by the pioneering work of John Ely,” said John Chisholm, Chairman, President and Chief Executive Officer of Flotek. “We are honored that John and his firm have agreed to a partnership that, we believe, brings a new dimension of service to Flotek’s technology offerings. The ability to provide our clients access to the preeminent stimulation and completion services in the industry as part of the experience of employing Flotek chemistry technologies will provide our clients additional confidence in their stimulation designs as well as oversight of the actual completion process and independent analysis of the results. Combined with our existing and emerging technologies, this process will result in a ‘complete client experience’ in which Flotek clients will benefit from the best expertise, the best chemistry and, as a result, the best completions in the industry.”

      “We are delighted to join with John and Flotek team to create a partnership that stands in support of optimal stimulation and completion practices,” said John Ely. “I have known and worked with John Chisholm for a number of years and respect and admire the technologies and work of the Flotek team. In my decades of experience, I have generally been skeptical of the impact of surfactants in the completion process. However, through personal experience with Flotek’s Complex nano-Fluid® chemistries and the compelling results from thousands of wells using the Company’s precision custom chemistries, I am convinced that nearly every fracture stimulation can benefit from the use of CnF® completion chemistries. We look forward to working with Flotek and clients – many of which are clients of our firm as well – to assist in maximizing production through the development of optimal completion protocol utilizing the next generation of completion chemistries.”

      Update on Third Quarter Operating Activity

      While Flotek is in the early stages of compiling its third quarter results the Company’s preliminary review suggests that Flotek’s chemistry segment showed strong sequential growth, outpacing overall oilfield activity.

      While results are subject to final accruals and review, Flotek believes that CnF® sales increased at least 25% when compared to second quarter CnF® sales, a direct result of growing interest in the Company’s precision, customized completion chemistries generated through a review of FracMax® data and validation results.

      The growth in CnF® sales should result in higher margins in the Energy Chemistry Technologies segment and gross profit which are expected to show an increase of at least 15% when compared to the second quarter segment gross profit. Such results are also expected to lead to an increase in operating income for the entire enterprise.

      “While we are in the early stages of compiling our financial results for the third quarter, we are pleased with the relative performance of our Energy Chemistry Technologies segment, driven entirely by growing acceptance and use of our patented, customized CnF® suite of completion chemistries,” added Chisholm. “While this market environment means we have to work harder for each new client, the empirical data from FracMax® showing the efficacy of CnF® and compelling results that result from validations continue to result in new CnF® clients. While the market environment remains difficult, we continue to see growing interest in CnF® and will continue to pursue every opportunity available to maintain our position as a leader in energy technology and value creation throughout the energy cycle.”

      Earnings Reporting Schedule and IPAA Presentation

      Flotek will host a conference call on Thursday, October 22, 2015, at 7:00 a.m. CDT (8:00am EDT) to discuss its financial and operating results for the three-months ended September 30, 2015. Flotek intends to provide dial-in information through a press release on October 21, 2015.

      Flotek plans to file its 10-Q after the market close on Wednesday, October 21, 2015. In addition, the Company will provide additional details regarding operating results in a press release after the market close on October 21, 2015.

      As a reminder, the company will also make a presentation at the Independent Petroleum Association of America (IPAA) San Francisco Oil and Gas Investment Symposium today, October 5, 2015. Mr. Chisholm will present to conference attendees beginning at 12:05 pm EDT (9:05 am PDT).
      Avatar
      schrieb am 22.10.15 13:52:07
      Beitrag Nr. 15 ()
      dem Markt gefallen die Q3-Zahlen anscheinend nicht:
      Flotek posted earnings for the quarter ending September 30, 2015 of $0.04 per common share (fully diluted) compared to earnings per share of $0.02 per common share (fully diluted), excluding non-recurring, non-cash charges, for the quarter ending June 30, 2015.

      Revenue for the third quarter, 2015 was $87.9 million, an increase of 1.0% from second quarter, 2015.

      Third quarter CnF® sales volumes were 34% greater than second quarter, 2015 volumes and 59% above third quarter, 2014 levels.

      Flotek recently announced a partnership with Ely & Associates (“Ely”), a leading international stimulation and completion consulting firm, under which Flotek and Ely will provide Flotek CnF® completion chemistry clients a suite of stimulation and completion consulting services to further extend Flotek’s reach as the leading North American completion chemistry and consulting services firm.


      HOUSTON, October 21, 2015 --

      Flotek Industries, Inc. (NYSE:FTK - News) ("Flotek" or the "Company") today announced results for the three months ended September 30, 2015.

      As reported on Form 10-Q filed with the U.S. Securities and Exchange Commission, Flotek reported that revenue for the three months ended September 30, 2015, was $87.9 million compared to $116.8 million for the three months ended September 30, 2014, and $87.0 million for the second quarter of 2015. Third quarter, 2015 revenue increased 1.0% sequentially but decreased 24.7% when compared to the same period in 2014.

      The decrease in year-over-year revenue was driven by the steep decline in oilfield activity; however, the increase in sequential revenue was driven almost entirely by increased sales of Flotek’s Complex nano-Fluid® completion chemistries, a direct result of the growing interest in the Company’s precision, customized completion chemistries generated through a review of FracMax® data and validation results.

      For the three months ended September 30, 2015, the Company reported net income from continuing operations of $2.0 million, or $0.04 per common share (fully diluted), compared to net income of $14.3 million, or $0.26 per common share (fully diluted) for the same period in 2014 and net income of $1.1 million or $0.02 per common share (fully diluted), excluding non-recurring, non-cash charges, in the second quarter of this year.

      “In arguably the most challenging operating environment in my career, Flotek’s ability to post sequential earnings growth and record CnF® chemistry volumes is a testament to the effort of the hardest working women and men in the oilfield technology business,” said John Chisholm, Chairman, President and Chief Executive Officer of Flotek.

      “Our third quarter results – especially the resilience of our proprietary, patented Complex nano-Fluid® suite of precision, customized completion chemistries – validate our belief that technology – in this case Flotek’s advanced completion chemistry – does make a meaningful, positive difference in well performance and economics and has become even more compelling in this challenging environment as companies look for ways to maximize economic return at the nadir of the commodity price cycle.”

      “The market penetration of CnF® is the primary result of two key corporate initiatives and innovations: the rapid growth and acceptance of FracMax®, Flotek’s patent-pending data analytics and visualization tool that provides uncontroverted empirical proof of the positive impact of CnF® on well performance and economics; and, the introduction of the Flotek Store™, a direct distribution model allowing our clients to buy Flotek from Flotek,” added Chisholm. “While we are aware of the headwinds ahead of us, especially in the holiday-focused fourth quarter, our recent results provide a plethora of evidence that CnF® has reached a ‘tipping point’ that will lead to accelerated adoption and long-term growth of our core chemistry business.”

      “In the past year, Flotek has grown its stable of CnF® ‘power users’ – those companies that we believe use CnF® on at least three-quarters of their completions – from just a handful to well over 30 today, another indication that Flotek’s Complex nano-Fluid® completion chemistries have gained considerable traction even as market activity decelerated,” added Chisholm. “Those companies – from leading independents to smaller, regional players – are not only the reason for our strong performance but also the impetus for future growth as their success stories will lead to the next generation of CnF® success stories. In fact, as a result of peer-to-peer discussions involving power users in the past months, several E&P companies that had not used CnF® prior to those discussions have joined our growing list of validations and new commercial clients.”

      “In addition to the direct benefits of CnF® completion chemistries, our clients – especially those taking advantage of our new direct distribution channel – benefit from the complete Flotek experience, including access to our state-of-the-art laboratory services and precision, customized molecular formulations to address specific well needs as well as our recently announced partnership with John Ely and his team, which adds an additional level of confidence that the benefits of CnF® will be optimized in the completion process,” noted Chisholm. “Combined with our introduction of FracMax Centric™ in the coming weeks, Flotek is quickly becoming the total completion technology partner for energy producers in North America.”

      Third quarter, 2015 CnF® volumes were 34% above second quarter levels and 59% above volumes in the third quarter of 2014. Third quarter, 2015 CnF® revenues were 32% above second quarter levels and 18% above third quarter, 2014 revenues. Chemistry gross margins also rose by over 400 basis points in the quarter when compared to the second quarter of 2015, primarily as a result of continued pricing stability among CnF® products and increased CnF® sales relative to other chemistries.

      “As we continue to respond to customer needs, we have added CnF® formulations to our stable of chemistries that address basin-specific needs,” added Chisholm. “In some cases, those products carry a lower cost of production, some of which we are able to pass on to our clients, which, in this operating environment, we believe is the right thing to do, creating a win-win for both Flotek and our clients. However, overall we have been able to hold firm on CnF® pricing products since March, an indication that our customers understand and embrace the value created by our unique chemistry technology.”


      Other Operational Highlights

      While the exceptional performance of Flotek’s Energy Chemistry Technologies segment was an important highlight in the quarter, several other items deserve mention.

      Flotek recently announced a technical partnership with Ely & Associates (“Ely”), a leading international stimulation and completion consulting firm, under which Flotek and Ely will provide Flotek CnF® completion chemistry clients a suite of stimulation and completion consulting services to further extend Flotek’s reach as the leading North American completion chemistry and consulting services firm. Through the partnership, Flotek will package Ely’s world-class reservoir stimulation and completion consulting services with the Company’s CnF® customized completion chemistries for those clients that purchase CnF® chemistries directly through the Flotek Store™.
      CnF® validations continued to grow during the quarter, both in terms of the number of customers as well as overall volume. In addition, conversions from validations to commercial customers continues to grow with over 30 companies now using Flotek’s completion chemistries on over 75% of total company completions, up from less than a dozen during the same period last year.

      In Canada, while the market remains even more challenged than domestic markets, Flotek completed an agreement with Engineered Chemistry, Inc. – led by a group of well-regarded Canadian geoscientists – to support Flotek’s direct distribution efforts north of the border.

      On the international front, Flotek continues a number of key initiatives in Saudi Arabia, including being one of the first non-pressure pumping companies to introduce completion chemistries directly into the Kingdom. In addition to other chemistries, Flotek was recently awarded and has completed initial scale inhibitor chemistry testing for Aramco with evaluation of the results underway. In the United Arab Emirates, Flotek is completing a warehousing and blending agency agreement which should lead to more efficient operations throughout the Middle East. In South America, Flotek should begin CnF® validations in Chile and Argentina in the fourth quarter.

      Despite a drop in the number of rigs in the Company’s Drilling Technologies serviceable areas, Flotek was able to increase the number of rigs serviced, a result of our concerted effort to hold and increase market share. Flotek’s innovative technologies, including TelePulseTM and the improved Stemulator®, as well as new drilling products like ProPulse, also helped partially offset the challenging operating environment.

      In Production Technologies, the Company continues to see positive impacts from its acquisition of International Artificial Lift, including a contract for the sale and installation of four new Hydralift units. Additionally, Flotek is proceeding with the launch of its next-generation electrical submersible pump (“ESPs”) sales program beginning in the fourth quarter. Preliminary product introductions have been well received from both current and potential customers.

      Flotek’s EOGA subsidiary continues to gain traction both domestically and internationally. Domestically, EOGA has made headway expanding its customer base by applying gel polymer for water shut-off in unconventional, multi-stage fractured Wolfcamp shale wells in the Permian Basin, followed by large volume CnF® treatments to stimulate oil flow. Additionally, EOGA began injecting CnF® into horizontal polymer flood injections to validate its effectiveness for use in chemical Enhanced Oil Recovery for a large international oil and gas producer.

      In the Company’s Consumer and Industrial Chemistry Technologies segment, the Company signed a number of new and renewal contracts with key consumer and industrial clients, providing good visibility for the balance of this year and into the first half of 2016. The Company also strengthened its raw material position by entering into strategic supply agreements for 2016 and beyond.

      The Company continues to progress on its new Global Research and Innovation facility in North Houston, with outside signage now in place and internal work underway. The 50,000 square foot facility will bring Flotek’s research team together under one roof and provide next-generation technology in an interactive setting, allowing clients to collaborate directly with Flotek’s research professionals, creating a more complete client experience.

      In addition, Flotek is completing additional storage capacity at its flagship Marlow, Oklahoma chemistry production facility to support the growth in CnF® sales and the Company’s direct distribution efforts.

      Flotek continues to consider opportunities to expand the reach of the Company’s DREAM™ big data analytics and visualization software, both by expanding the applications for FracMax® in the energy space as well as new applications beyond the energy space. In conjunction with several stakeholders, Flotek is engaged in discussions with a variety of parties to explore a number of initiatives related to the Company’s emerging software platform.
      Financial Update

      A complete review and discussion of the Company's quarter-end financial performance and position can be found in the Company's quarterly report on Form 10-Q filed with the U.S. Securities and Exchange Commission today.

      Adjusted Earnings Before Interest, Taxes, Depreciation and Amortization, or Adjusted EBITDA (a non-GAAP measure of financial performance), for the three months ended September 30, 2015 was $7.3 million compared to $25.2 million for the three months ended September 30, 2014.

      The Company recorded stock-based compensation expense during the quarter of $3.6 million ($2.3 million, net of tax at 35%). That compares to stock-based compensation expense in the third quarter of 2014 of $2.7 million ($1.7 million, net of tax at 35%).

      A presentation of stock-based compensation and a reconciliation of GAAP net income to Adjusted EBITDA can be found at the conclusion of this release.

      Cash flow from operations for the nine months ended September 30, 2015, was $17.8 million, compared to $39.9 million for the nine months ended September 30, 2014. Operating cash flow for the 2015 period was used primarily to expand capital facilities and to make required payments on the Company’s term note. Borrowings under the Company’s revolving line of credit were primarily used to repurchase Company stock in open market transactions and for tax withholding upon the vesting of employee stock awards.

      Net debt improved to $44.8 million at the end of third quarter of 2015 compared to $49.7 million at the end of the second quarter of 2015.

      Inventories were $84.4 million as of September 30, 2015, essentially unchanged compared to inventories as of June 30, 2015.

      Outstanding receivables, net as of September 30, 2015, were $52.1 million, compared to $56.5 million as of June 30, 2015. The Company’s days sales outstanding (“DSO”) improved to 54 days at the end of the third quarter of 2015 compared to 59 days at the end of the second quarter of 2015. The Company’s allowance for doubtful accounts represented 1.7% of receivables at September 30, 2015.

      Depreciation and amortization expense, excluding depreciation and amortization included in cost of sales, for the three months ended September 30, 2015, increased by $0.3 million when compared to the same period in 2014.

      Interest and other expense decreased $0.1 million for the three months ended September 30, 2015 as compared to the same period of 2014.

      The Company recorded an income tax provision of $0.4 million and a benefit of $6.5 million, yielding effective tax rates of 16.8% and 34.9% for the three and nine months ended September 30, 2015, respectively, compared to income tax provisions of $6.1 million and $18.4 million reflecting effective tax rates of 29.8% and 33.0% for the comparable periods in 2014. The lower effective tax rate for the three months ended September 30, 2015, is primarily due to the mix of pre-tax profit and loss between domestic and foreign jurisdictions.

      Segment Details

      Energy Chemistry Technologies segment reported revenue of $60.2 million for the three months ended September 30, 2015. Energy Chemistry Technologies revenue for the three months ended September 30, 2015, decreased $8.0 million, or 11.7%, relative to the comparable period of 2014, compared to a 53.9% decline in market activity as measured by average North American rig count. Revenue for the nine months ended September 30, 2015, decreased $29.9 million, or 15.5%, relative to the comparable period of 2014, compared to a 43.2% decline in market activity. The Energy Chemistry Technologies segment substantially outperformed the market activity indicators due to significant increases in CnF® sales volumes during the quarter. CnF® sales volumes increased 34% for the three months ended September 30, 2015, compared to the three months ended June 30, 2015, and increased 59% compared to the three months ended September 30, 2014. The increased sales of CnF® during the third quarter of 2015 were due to Flotek’s continued aggressive promotion of the benefits of CnF® in completions and re-stimulation efforts by leveraging the quantitative evidence demonstrated through the FracMax® analytical platform. These strategic sales and marketing efforts are ensuring that Flotek remains a leader in the energy chemistry industry and is poised to take even greater advantage of any market recovery.

      Income from operations for the Energy Chemistry Technologies segment of $14.3 million decreased $5.6 million, or 28.2%, for the three months ended September 30, 2015, and decreased $27.7 million, or 45.6%, for the nine months ended September 30, 2015, relative to the comparable periods of 2014. The decrease in income from operations for both periods is primarily attributable to the decrease in gross margin and increased headcount during late 2014 and in the first half of 2015. Headcount has increased in the sales organization to pursue growth opportunities, and in R&I, related to new product development and increased demand for existing product support as the segment continues to refocus and reposition for growth in the market.

      Despite a drop in the number of rigs in our Drilling Technologies serviceable areas, Flotek was able to increase the number of rigs serviced by the Company compared to the second quarter 2015, a result of our concerted effort to hold and increase market share. Flotek’s innovative technologies, including TelePulseTM and the improved Stemulator® as well as new drilling products like ProPulse, should help partially offset the challenges Drilling Technologies faces from the declining rig activity. Flotek is beginning to see more marginal companies falling out of the market, as the Company contends that pricing pressures may have hit their apex.

      Though early in the quarter, Flotek expects the fourth quarter to look similar to third quarter results, with cost cutting efforts continuing as the Company works to reduce cash burn rates in the business.

      Drilling Technologies revenue of $10.8 million decreased $19.1 million, or 63.9%, and decreased $40.2 million, or 49.0%, for the three and nine months ended September 30, 2015, respectively, relative to the same periods in 2014, due to decreased actuated tool rentals, a decrease in Teledrift® domestic rental revenue, and decreased product sales. The revenue declines were primarily related to the decrease in drilling rig activity for the three and nine months ended September 30, 2015.

      Income from operations for the Drilling Technologies segment for the three and nine months ended September 30, 2015, decreased by $8.2 million and $37.6 million, respectively, compared to the same periods of 2014, primarily resulting from the second quarter 2015 impairment charge. Income from operations, excluding the impairment, for the nine months ended September 30, 2015, decreased by $18.1 million over the same period of 2014. The decreases in income from operations for the three and nine months ended September 30, 2015, were primarily due to reductions in revenue and pricing pressure that resulted in customer price reductions, partially offset by reductions in direct and indirect costs resulting primarily from headcount reductions and other cost reduction measures.

      Flotek’s Production Technologies gained positive momentum during the third quarter. The Company continues to experience positive impacts from its acquisition of International Artificial Lift, as Flotek was awarded its first four domestic Hydralift installs. Additionally, Flotek is proceeding with an electrical submersible pump launch scheduled for the fourth quarter 2015. Preliminary product introductions have been well received from both current and potential customers.

      Revenue for the Production Technologies segment of $3.1 million for the three months ended September 30, 2015, decreased by $1.9 million, or 37.7%, from the same period in 2014 due to decreased sales of international Petrovalve® equipment. For the nine months ended September 30, 2015, revenue decreased by $0.7 million, or 6.8%, relative to the same period in 2014 as lower international Petrovalve® sales were partially offset by increases in domestic rod pump equipment sales.

      Income from operations for the Production Technologies segment decreased $2.4 million and $4.9 million for the three and nine months ended September 30, 2015, compared to the same periods in 2014. Income from operations, excluding the impairment, decreased by $4.1 million for the nine months ended September 30, 2015, compared to the same period in 2014. These decreases are primarily due to product mix and increases in SG&A costs attributable to employee-related expenses as the segment continues to refocus and reposition for growth. The Production Technologies segment’s progress towards serving the oil market should build on the recent growth position achieved in the domestic rod pump market. New product and service offerings are being introduced in the last quarter of 2015, including new technologies in hydraulic pumping units and ESPs. These new products will position the Company for differentiation in the oil basins currently pursued by Production Technologies.

      Sales in the company’s Consumer and Industrial Chemistry Technologies (“CICT”) segment remained strong and increased slightly when compared to the same period in 2014. Although lower than 2014 levels, demand for the segment’s higher margin flavor and fragrance business continues to improve. CICT remains well positioned on inventory and forward purchases to support both internal and external needs.

      CICT revenue of $13.9 million increased $0.2 million, or 1.1%, and $3.5 million, or 8.8%, for the three and nine months ended September 30, 2015, respectively, versus the comparable periods of 2014, primarily due to increased terpene sales.

      Income from operations for the CICT segment was essentially flat for the three months ended September 30, 2015, and increased $1.7 million, or 34.1%, for the nine months ended September 30, 2015, compared to the same periods of 2014. The increase in income from operations was primarily due to increased terpene sales and reductions in SG&A expenses resulting from cost control measures.

      Fourth Quarter Outlook

      “While we are pleased with our third quarter performance, especially given the challenging operating environment and decline in overall oilfield activity, we continue to more aggressively pursue additional growth opportunities, especially for Flotek’s world-class, precision, customized chemistry in North America and beyond,” added Chisholm. “While we understand the challenges that the holidays present in the fourth quarter, we will continue to be diligent in completing validations and converting those projects into long-term clients, focusing on the value created by using CnF® to maximize well value through enhanced completions. In addition, we are acutely focused on validations by large, independent operators that will begin in the fourth quarter with an eye to evaluation and client conversion in the New Year.”
      1 Antwort
      Avatar
      schrieb am 22.10.15 13:53:37
      Beitrag Nr. 16 ()
      Antwort auf Beitrag Nr.: 50.906.877 von R-BgO am 22.10.15 13:52:07
      das nenne ich Preisdruck:
      für 159% Volumen nur 118% Umsatz heißt 25,2% Rabatt...
      Avatar
      schrieb am 22.10.15 13:56:09
      Beitrag Nr. 17 ()
      Antwort auf Beitrag Nr.: 49.644.758 von Mistsack am 26.04.15 10:08:20
      vielleicht nicht nur...
      Zitat von Mistsack: Flotek ist ein interessanter Wert. Allerdings waren die letzten Quartalszahlen grausam. Scheint mir ein klassischer play auf den turnaround der Ölpreise.



      FracMax ist irgendwie auch ein Softwareplay
      http://seekingalpha.com/article/3518836-flotek-activist-inve…
      6 Antworten
      Avatar
      schrieb am 22.10.15 14:03:58
      Beitrag Nr. 18 ()
      Antwort auf Beitrag Nr.: 50.906.916 von R-BgO am 22.10.15 13:56:09auf alle Fälle. Allerdings waren die Zahlen jetzt nicht der Brüller. Damit dürfte die Aufwärtsbewegung erstmal gestoppt sein.
      Avatar
      schrieb am 10.11.15 18:10:01
      Beitrag Nr. 19 ()
      Antwort auf Beitrag Nr.: 50.906.916 von R-BgO am 22.10.15 13:56:09
      UUUPPS!:
      http://brontecapital.blogspot.de/2015/11/flotek-plea-for-acc…
      4 Antworten
      Avatar
      schrieb am 10.11.15 20:45:49
      Beitrag Nr. 20 ()
      Antwort auf Beitrag Nr.: 51.055.197 von R-BgO am 10.11.15 18:10:01
      Antwort von Flotek:
      HOUSTON, November 10, 2015 /PRNewswire/ --

      In conjunction with Flotek Industries, Inc. (“Flotek” or the “Company) presentation at the Stephens, Inc. Fall Investment Conference in New York City, Flotek provides the following update on the ongoing development and evolution of the Company’s FracMax® data analytics and visualization software application.

      Flotek has carefully reviewed a recent report regarding the validity of the data from the Company’s FracMax® database by analyzing data from a small subset of wells in FracMax®. The analysis suggests the production data presented by Flotek – for three of the wells analyzed – were misinterpreted by Flotek and understated the production of those wells.

      “We take any contention of errors in our data, processes and analysis very seriously,” said John Chisholm, Chairman, President and Chief Executive Officer of Flotek. “We appreciate the thorough analysis provided in the report and are using this critique as well as others to improve our FracMax® application to ensure both the validity and reliability of the underlying data as well as the accuracy of the analytical processes.”

      As a result of our initial review of the report we have concluded that the FracMax® database – partly a result of third party data used by Flotek – identified the three wells in question to be contained in units with multiple wells (the state of Texas organizes production reporting by units, or leases, that report total production in the aggregate). The FracMax® application uses algorithms to assign production to individual wells within multiple well units. In this case, the report contends that the wells in question were on single-well units and, as a result, 100% of the production from those units should be assigned to the identified wells. After review of the report, data from the Texas Railroad Commission as well as other third-party data providers, it appears that the wells in question are single-well units.

      While the adjustment does impact the magnitude of the outperformance of the well completed using CnF® when compared to the non-CnF® treated wells, it does not, the Company believes, change the conclusion that the CnF® well outperformed the non-CnF® wells, especially when normalized for the length of the lateral completion zone.

      “While we are concerned by the unintentional data and processing error that led to this unitization miscalculation and are taking aggressive steps to ensure this process is immediately corrected, our analysis of the wells in question concludes the use of CnF® improved productivity when compared to the neighboring wells that did not use CnF® in the completion process,” said Chisholm. “Moreover, Sabine Oil & Gas – the operator of three of the wells in question – continues to use CnF® on its completions, an indication that Sabine’s internal data show compelling benefits from the use of Flotek’s Complex nano-Fluids® suite of completion chemistries.”

      The Company has conducted an initial review of the FracMax® database and has determined that this data and process error does not impact the vast majority of wells in the database which appear to be unitized appropriately by the software application. “In fact, there were several other wells in the investor presentation that were unitized and reported correctly, showing the benefits of CnF® that were not discussed or referred to in the report,” added Chisholm.

      “While FracMax® is an important tool in the development of new markets for CnF®, the most important determinant of the success of CnF® is the actual performance of the Company’s completion chemistry in the wells of new and existing clients,” said Chisholm. “The growth in validations that result in new commercial customers is the ultimate proof of the efficacy of our completion chemistries. Our clients and their experiences – as seen through their own proprietary production data – are by far the best evidence of the performance-enhancing nature of CnF®.”

      The number of production companies using CnF® in the completion process continues to grow with a consistent flow of validation projects for operators of all sizes.


      Appointment of Independent Verification Team

      In support of accuracy, transparency and credibility of FracMax® and its database, Flotek also announced today the appointment of a committee to ensure process precision and data accuracy in FracMax®. Among other items the committee is charged with the immediate development of a framework for the comprehensive analysis and evaluation of FracMax® and the engagement of an independent team to evaluate and audit the FracMax® software processes and database to ensure precision of process and accuracy of the database.

      Members of the three-person committee are:

      David Nierenberg is the founder of Nierenberg Investment Management, manager of D3 Family Funds, a Pacific Northwest investment management firm. Prior to founding Nierenberg, David spent seven years at Bain & Company. Nierenberg graduated summa cum laude from Yale College before earning his law degree from Yale Law School.

      Ted Brown has been a Director of the Board since November 2013. Recently retired, Ted was responsible for the northern region of Noble Energy’s United States division. Elected Senior Vice President in April 2008, he previously served as Vice President for the same region since August 2006. He joined the company as Vice President of the United States Division in May 2005, when Noble Energy acquired Patina Oil & Gas Corporation. Previously, he spent more than ten years with Williams and Barrett Resources. He holds a Bachelor of Science degree in mechanical engineering from the University of Wyoming.

      John Ely attended Oklahoma State University, graduating with a degree in Chemistry in 1968. While still in school, John joined Halliburton as a technician in their analytical group in 1965. In 1973 he moved into international operations where he served in roles of growing responsibility around the globe until he returned to the U.S., becoming technical advisor to Halliburton’s international operations in 1977. In 1985, Mr. Ely joined S.A. Holditch and Associates as Vice President of Stimulation Technology where he was instrumental in the firm’s stimulation chemistry research, much of the work under the auspices of the Gas Research Institute. He is a member of the American Chemical Society, The Society of Petroleum Engineers, and is a fellow of the American Institute of Chemistry. Mr. Ely’s firm and Flotek have an agreement whereby Ely & Associates provide certain completion consulting services to Flotek’s clients.

      The committee and engaged advisors will provide a report on their findings and any recommendations to Flotek’s Board of Directors. It is anticipated that a summary of the findings, recommendation and the Company’s action plan will be provided to shareholders and the public in early 2016.

      “We believe this is a natural next step in the evolution of FracMax® and our data offerings and is an important component of our commitment to transparency to our stakeholders,” added Chisholm. “I have said that transparency and clear communication with our stakeholders is an important tenant of my leadership at Flotek. While we may not always be perfect, we will always strive to get things right and do so in the right way.”


      FracMax® Public Availability

      A final assertion made in the report claims that attempts to download FracMax® for personal use resulted in iPad malfunctions and no success in obtaining an operating version of the software application. The author concludes that the program does not operate properly.

      As the Company has consistently noted since inception, FracMax® is a proprietary software application for the exclusive internal use of Flotek employees. While the Company is preparing to release a new version of the software available for use by operators, FracMax® is not currently available outside of Flotek employees. A key code as well as other security requirements are necessary to obtain a working copy of the FracMax® application. This has been a consistent policy since FracMax® was introduced in 2014.
      2 Antworten
      Avatar
      schrieb am 10.11.15 21:12:41
      Beitrag Nr. 21 ()
      Antwort auf Beitrag Nr.: 51.056.556 von R-BgO am 10.11.15 20:45:49
      Diese Antwort erklärt nicht,
      warum man Produktionsmonate ganz weggelassen hat

      und auch nicht

      wofür man die App bei Apple hochgeladen hat.


      Fühlt sich nicht gut an...
      1 Antwort
      Avatar
      schrieb am 11.11.15 10:17:36
      Beitrag Nr. 22 ()
      Antwort auf Beitrag Nr.: 51.056.712 von R-BgO am 10.11.15 21:12:41Volle Zustimmung....hier stehen noch ein paar Schmerzen ins Haus. Und man wird abwarten müssen, wie sich die Lüge auf den Verkauf von CnF auswirken wird. Vermutlich muss man die nächsten Quartalszahlen abwarten.

      Sollte sich alles als ok herausstellen, könnte es jedoch ein wirklich günstiger Kauf sein.
      Avatar
      schrieb am 15.01.16 12:13:31
      Beitrag Nr. 23 ()
      Antwort auf Beitrag Nr.: 48.940.223 von R-BgO am 30.01.15 23:15:37
      bin zu 15$ ausgeübt worden
      :O:O

      Zitat von R-BgO:
      Zitat von R-BgO: zu 3,5x verkauft...


      leider nur geringe Stückzahl



      ach ja, seit heute wieder drin mit einer halben Position zu $16,21

      auf die habe ich einen Jan2016 short-call mit strike 17,50 verkauft für $2,05


      über die gleiche Stückzahl habe ich Jan2016 einen short-put mit strike 15$ verkauft zu $2,10;


      damit profitiere tendenziell davon, wenn wenig passiert:

      pro Kontrakt habe ich eingesetztes Kapital von 1.621+1.500-205-210 = $2.706

      wenn der Kurs am Ende über 17,50 steht, dann bleiben 1.500+1.750 = 3.250 übrig => Rendite 20,1%
      wenn der Kurs am Ende unter 15,00 steht, dann habe ich einen Durchschnittseinstand von 2.706/200 = $13,53 (also 16,5% Rabatt auf den heutigen Kurs)

      und dazwischen ist es auch ok
      8 Antworten
      Avatar
      schrieb am 17.01.16 14:30:33
      Beitrag Nr. 24 ()
      Antwort auf Beitrag Nr.: 51.499.425 von R-BgO am 15.01.16 12:13:31Da liegst du jetzt 40% hinten mit der Position, oder? Die Bewegung der Aktie war einfach zu groß für deinen Straddle, wenn ich das richtig sehe?
      6 Antworten
      Avatar
      schrieb am 17.01.16 16:53:53
      Beitrag Nr. 25 ()
      Antwort auf Beitrag Nr.: 51.512.724 von Mistsack am 17.01.16 14:30:33
      so isses' wohl...
      jetzt warte ich erstmal die Zahlen ab;

      sollen schon kommende Woche da sein
      5 Antworten
      Avatar
      schrieb am 17.01.16 17:37:31
      Beitrag Nr. 26 ()
      Antwort auf Beitrag Nr.: 51.513.372 von R-BgO am 17.01.16 16:53:53es krabbelt mir auch in den Fingern, mir bei den Kursen eine erste Position zuzulegen. Flotek wird auf alle von einem Aufschwung der Ölpreise profitieren. Aber die Gesamtmarktlage lässt mich aktuell noch zögern. Der finale Sell-Off fehlt mir irgendwie noch.
      Avatar
      schrieb am 19.01.16 14:20:38
      Beitrag Nr. 27 ()
      Antwort auf Beitrag Nr.: 51.513.372 von R-BgO am 17.01.16 16:53:53
      Flotek Industries Announces Retention of MHA Petroleum Consultants
      by CnF® Special Technical Committee; Announces Select, Preliminary Fourth Quarter Results; Appointment of Independent Board Committee and SEC Inquiry; Reaffirms Fourth Quarter and Year-End Earnings Release Date and Conference Call Schedule


      HOUSTON, January 19, 2016 /PRNewswire/

      Flotek Industries, Inc. (NYSE: FTK - News) (“Flotek” or the “Company”) announced today that the Special Technical Committee (the “ Technical Committee”) appointed to develop an independent methodology to analyze the performance of Flotek’s CnF® chemistries has retained MHA Petroleum Consultants, LLC (“MHA”) of Denver as the principal investigators for the project.

      The Company also provided commentary on fourth quarter activity, the creation of a special committee of independent directors to direct the review of issues related to the Company’s FracMax® software and the efficacy of CnF®, and notice from the U.S. Securities and Exchange Commission of an inquiry related to FracMax® software and the efficacy of CnF®.

      Special Technical Committee Retention of MHA Petroleum Consultants

      The Technical Committee, formed to review issues surrounding the Company’s FracMax® software and the efficacy of CnF® in completions, announced that it retained Denver-based MHA Petroleum Consultants as advisors to assist in its charge of independently validating the effectiveness of CnF® and assist in the review of the FracMax® software and associated database.

      MHA is an oil and gas consulting concern that provides a broad range of services, such as corporate planning and reporting, acquisition and disposition, litigation support and identification of optimal plans for field development and depletion. MHA conducts reserve and resource evaluations in the U.S. and internationally, onshore and offshore. MHA has experience in converting complex technical reservoir data, production forecasts, and economic information into reserve and resource valuations. Its integrated analysis incorporates the disciplines of geophysics, geology, petrophysics, production facility engineering, economic valuation and risk assessment. The firm assists companies across the energy spectrum in analyzing production and reserve data, including the evaluation of various drilling, completion and production techniques and strategies.

      Tim Hower, MHA’s Chief Executive Officer, is the principal investigator conducting the CnF® studies. Mr. Hower has over thirty years of petroleum engineering evaluation experience spanning a broad range of issues including unconventional reservoir assessment and reserves, field development planning, reservoir simulation and enhanced recovery. He holds a BS in petroleum engineering and an MS in petroleum engineering, both from Pennsylvania State University. Mr. Hower is a licensed petroleum engineer in the state of Colorado and Wyoming.

      MHA’s work began in November 2015 with the development of a methodology to assess the impact of CnF® on production, including attention to data collection focused on ensuring, as much as possible, the accuracy of third party data to be used in the analytical model. MHA has been tasked with reviewing CnF® performance in three basins: The Denver-Julesburg Basin of Colorado, the Permian Basin of Texas and the South Texas Basin. It is anticipated that the results will be released on a basin-by-basin basis, beginning with the Denver-Julesburg Basin, once the studies are completed and reviewed.

      MHA began its investigation in the Denver-Julesburg Basin because of readily available data for this basin, including both input data as well as well-centric production data. As the Company noted in its November 2015 release regarding issues and errors in the FracMax® analytical process, production data from Texas is aggregated by lease or unit, making analysis of individual well production data more complex and time-consuming.

      Preliminary Fourth Quarter Activity Commentary

      While the Company is still finalizing results for the quarter and year ending December 31, 2015, Flotek today provided the following color on select operations for the three-months ended December 31, 2015.

      While overall oilfield activity continued to see sequential declines in the fourth quarter, the Company’s CnF® chemistry business was resilient in the three-month period. CnF® volumes in the fourth quarter are expected to increase by approximately 5% and, when compared to the fourth quarter of 2014, are expected to increase by greater than 20%. CnF® revenues are likely to be flat when compared to third quarter revenues and down approximately 4% when compared to year-ago levels. The expected decline in revenues is primarily a result of a combination of previously discussed product substitution and volume incentive pricing to large customers.

      The non-CnF® chemistry business is expected to be meaningfully weaker due to the overall deceleration in market activity and activity curtailment by a major customer in the quarter. Similarly, the Company anticipates the Drilling Technologies segment to post a decline of approximately 5% in sequential revenue and over 60% in year-over-year sales, consistent with overall deterioration in industry activity.

      “We are pleased with the strength in CnF® activity, especially given the sharp decline in overall oilfield activity,” said John Chisholm, Flotek’s Chairman, President and Chief Executive Officer. “We believe continued market penetration and the positive impact on client performance have helped us increase CnF® volumes in a very difficult oilfield environment. While we understand the challenges ahead, we plan to continue our strategy to build the validation portfolio and work hard to convert those validations into commercial clients regardless of the market environment.”

      Establishment of Special Committee and SEC Inquiry

      As a result of issues raised in an independent report regarding the accuracy of the Company’s FracMax® software and efficacy of the Company’s CnF® completion chemistries, the Company was named as a defendant in a number of shareholder class action and derivative lawsuits. In addition, the Company received notice from the U.S. Securities and Exchange Commission (“SEC”) that it has opened an inquiry related to similar issues.

      The Company's Board of Directors subsequently formed a Special Committee consisting of five independent members of the Board of Directors to conduct an independent review of the issues as well as any other relevant issues that may arise in connection with the shareholder litigation or SEC inquiry.
      3 Antworten
      Avatar
      schrieb am 19.01.16 14:21:33
      Beitrag Nr. 28 ()
      Antwort auf Beitrag Nr.: 51.527.790 von R-BgO am 19.01.16 14:20:38
      weiß nicht warum,
      aber Bauchgefühl ist mau...
      1 Antwort
      Avatar
      schrieb am 21.01.16 10:45:39
      Beitrag Nr. 29 ()
      Antwort auf Beitrag Nr.: 51.527.799 von R-BgO am 19.01.16 14:21:33Jetzt kommt auch noch eine SEC investigation dazu. Ich halte mal lieber die Füße noch ein paar Tage still.
      Avatar
      schrieb am 02.05.16 19:02:53
      Beitrag Nr. 30 ()
      irgendwer 'ne Ahnung, was das sein könnte? HAL & BHI?
      HOUSTON, May 2, 2016 /PRNewswire/ --

      Flotek Industries, Inc. (NYSE: FTK - News) (“Flotek” or the “Company”) this morning announced that due to breaking industry events the Company has chosen to reschedule its first quarter earnings release and conference call.

      Flotek will now host a conference call on Wednesday, May 4, 2016, at 7:30 a.m. CDT (8:30 a.m. EDT) to discuss its financial and operating results for the three-months ended March 31, 2016. Flotek intends to provide dial-in information through a press release on May 3, 2016.

      Flotek plans to file its 10-Q after the market close on Tuesday, May 3, 2016. In addition, the Company will provide additional details regarding operating results in a press release after the market close on May 3, 2016.

      “With the major announcement over the weekend and subsequent conference calls now scheduled for tomorrow, it is appropriate for Flotek to push our conference call back a day to allow investors to focus on these events,” said John Chisholm, Chairman, President and Chief Executive Officer of Flotek. “We also look forward to the additional industry color likely to result from these calls, working with both clients as independent companies in the future and visiting with the investment community on Wednesday morning.”
      Avatar
      schrieb am 25.07.16 13:14:58
      Beitrag Nr. 31 ()
      Flotek Industries and YPF Technologia S.A. Sign Joint Technology Development Agreement

      HOUSTON, TX and BUENOS AIRES, ARGENTINA --- July 25, 2016 --


      Flotek Industries, Inc. (NYSE: FTK - News) (“Flotek” or the “Company”) announced today that it has signed a five-year joint technology development agreement with YPF Technologia S.A. (“Y-TEC”), the technology arm of YPF Sociedad Anonima (“YPF”), the vertically-integrated national energy company of Argentina.

      Flotek and Y-TEC will jointly work to develop new technologies and new applications of current technologies with a focus on the oil and gas industry as well as industrial applications beyond energy.

      Flotek and Y-TEC’s initial collaboration in the energy space will focus on:


      The use of customized chemistry to develop "full fluid systems", building from Flotek's patented CnF® and PrF™ technology platforms for deployment in both the Vaca Muerta shale and Neuquen tight gas basins.
      Design and implementation of a YPF-centric data management application emphasizing chemistry.
      Local supply and production of d-limonene (citrus terpenes) for applications in new and existing wells as well as other industrial and commercial applications.

      "We believe Y-TEC’s partnership with Flotek, focused on innovative custom chemistry, combined with integrated data analysis will enable us to continue to design more efficient and effective solutions for the development of both conventional and unconventional resources,” said Ing. Santiago Sacerdote, Gerente General of Y-TEC. “Y-TEC fully embraces Flotek's philosophy of ‘enabling and protecting reservoirs’ with the appropriate applications of precision, customized chemistry."

      "We are pleased to partner with Y-TEC in their efforts to embrace and deliver innovative technology in the energy sector as well as other industries in Argentina,” said John Chisholm, Flotek’s President, Chairman, and Chief Executive Officer. “The planned openings of Y-TEC’s ambitious new research facility as well as Flotek's new Global Research and Innovation Center in the coming months illustrate both companies are committed to cutting-edge research and innovations and further supports our collaborative effort that will include the sharing of research personnel and resources across the Americas.”
      Avatar
      schrieb am 27.07.16 14:42:04
      Beitrag Nr. 32 ()
      FLOTEK ANNOUNCES ACQUISITION OF INTERNATIONAL POLYMERICS, INC., ADDING TO SPECIALITY CHEMISTRY BUSINESS AND ENABLING FURTHER PRESCRIPTIVE CHEMISTRY MANAGEMENT™ OPPORTUNITIES

      HOUSTON, July 27, 2016 /PRNewswire/ --


      Flotek Industries, Inc. (NYSE:FTK - News) ("Flotek" or the "Company") announced today its intent to acquire International Polymerics, Inc. (“IPI”), and affiliates, for consideration consisting of cash and Flotek common stock. The acquisition will be treated as an asset purchase for income taxation purposes. Included in the assets will be approximately $1.2 million in working capital.

      Flotek will pay approximately $7.9 million in cash and issue approximately 248,000 shares of common stock as consideration for the acquisition.

      Founded in 2004, IPI is based in Dalton, Georgia with a distribution center in Monahans, Texas and is one of the largest domestic suppliers of natural polymers, including guar, to the oil and gas industry. IPI was founded by Donald Bramblett, a leading expert of natural polymers and the development of guar applications in the energy and textile trades. IPI’s proprietary guar processing systems have provided high-quality guar powder and slurry to oil and gas clients for nearly a decade in nearly every producing basin in the United States.

      “We are pleased that Donald, Mark and their team have agreed in principal to become part of Flotek,” said John Chisholm, Flotek President Chairman and Chief Executive Officer. “The IPI team has worked hard over the past twelve years to build a resilient business focused on providing best-in-class polymers to the energy and textile industries. Donald Bramblett is widely regarded as one of the world’s top experts on natural polymers and guar, adding more firepower to Flotek’s leading oilfield chemistry research team. And, the addition of polymer chemistry and delivery systems to Flotek’s stable of oilfield chemistry allows us to further accelerate our Prescriptive Chemistry Management™ efforts, focused on providing total chemistry solutions for our clients’ wells. We look forward to integrating IPI into the Flotek family.”

      Chisholm added, “IPI has high strategic value for Flotek in both the application of polymer chemistry to new, value-added oilfield chemistries as well for its core guar powder and slurries which serve as key delivery media for Flotek’s proprietary chemistries such as PrF™ and CnF® completion chemistries. This acquisition should allow us to accelerate our fluid systems development while adding-value and increasing margins in IPI’s core guar business using our direct distribution network.”

      “Finally, we believe that the IPI acquisition opens the door to natural polymer applications in other industrial segments,” concluded Chisholm. “Moreover, the Monahans, Texas facility is advantageously located in the heart of the Permian Basin which provides a strategic base from which to operate Flotek’s regional chemistry operations, creating efficiencies not presently available.”

      “In 12 years of operations, IPI has a solid profitability record and we believe will continue to focus on improving business operations and efficiencies as well as creating exceptional products that Flotek can market to its existing client base,” said Chisholm. “We also believe we have opportunities through innovation and our distribution network to meaningfully improve margins of the base business as well as create innovative, value-added products based on IPI’s polymer chemistry.”

      Donald Bramblett will remain the President of IPI and will report to Josh Snively, Executive Vice President of Flotek who oversees the Company’s chemistry manufacturing efforts.

      The transaction is scheduled to close coincident with the execution of the Stock Purchase Agreement and will become a part of Flotek’s Energy Chemistry reporting segment.
      1 Antwort
      Avatar
      schrieb am 27.07.16 14:47:04
      Beitrag Nr. 33 ()
      Antwort auf Beitrag Nr.: 51.527.790 von R-BgO am 19.01.16 14:20:38der Exculpierungsbericht ist fertig:


      "Conclusions and Limitations

      Both studies – the Permian Basin and the Eagle Ford Shale Play evaluations – conclude with the same summary:

      “Throughout this process, MHA has identified multiple discrepancies within the available data. These discrepancies varied depending on the source from which the data were acquired. While MHA has attempted to correct for these discrepancies, and to remove any wells which did not meet the stated guidelines, it should be noted that the quality and completeness of the data available from the Permian Basin [and Eagle Ford Shale play] is substantially inferior to the data available from the DJ Basin of Colorado. That being said, it is the opinion of MHA that the conclusions reached in this evaluation are robust and defensible due to the restrictions placed on the wells and leases included in the analyses. It should be noted that the results presented in this report are considered initial results specific to the areas studied within the Permian Basin [Eagle Ford Shale play]. . .”"
      Avatar
      schrieb am 27.07.16 14:54:15
      Beitrag Nr. 34 ()
      Antwort auf Beitrag Nr.: 52.927.549 von R-BgO am 27.07.16 14:42:04da ham'se sich jedacht, lass' mal paar mehr nehmen, vielleicht merkt's ja keiner...:

      (für die Akquisition hätten 630.000 Aktien gereicht)



      Flotek Industries, Inc. Announces $30 Million Common Stock
      Private Placement


      HOUSTON, July 27, 2016 — Flotek Industries, Inc. (NYSE: FTK) today announced that it has entered into definitive subscription agreements with accredited investors with respect to the private placement of shares of common stock for gross proceeds of approximately $30 million.

      Private Placement

      Flotek has entered into subscription agreements to sell an aggregate of 2,455,839 shares of common stock at a price of $12.52 per share. The closing and funding of the private placement is scheduled to occur on or about July 27, 2016.

      Flotek will use the proceeds of the private placement to fund the acquisition also announced this morning of International Polymerics, Inc., to repay indebtedness under the Company’s secured credit facility and for general corporate purposes.

      The shares of common stock have not been registered under the Securities Act of 1933, as amended, and such securities may not be offered or sold in the United States absent a registration statement or exemption from registration.
      Avatar
      schrieb am 27.07.16 14:58:37
      Beitrag Nr. 35 ()
      Antwort auf Beitrag Nr.: 51.499.425 von R-BgO am 15.01.16 12:13:31
      Nachtrag zum Thema Optionen:
      natürlich wurden die Dinger im Januar zu $15 angedient;

      habe sie erstmal liegen lassen und vergangene Woche neu mit strike 17$ per Jan18 neu veroptioniert.


      Auf und nieder, immer wieder....
      Avatar
      schrieb am 27.07.16 16:03:36
      Beitrag Nr. 36 ()
      Die Zahlen von gestern sehen auf den ersten Blick erstmal gut aus.
      Avatar
      schrieb am 08.12.16 10:08:25
      Beitrag Nr. 37 ()
      Antwort auf Beitrag Nr.: 51.055.197 von R-BgO am 10.11.15 18:10:01http://brontecapital.blogspot.de/2016_12_01_archive.html
      Avatar
      schrieb am 24.05.17 16:46:38
      Beitrag Nr. 38 ()
      Flotek Industries, Inc. Announces Closing Of Drilling Technologies And Production Technologies Sales

      HOUSTON, MAY 24, 2017 --

      Flotek Industries, Inc. ("Flotek" or the "Company") (NYSE: FTK) has closed on the sales of its Drilling Technologies and Production Technologies segments. As previously disclosed, the Drilling Technologies division has been sold to National Oilwell Varco, L.P. (“NOV”) for final consideration of $17 million, subject to normal working capital adjustments.

      The Production Technologies segment has been acquired for total consideration of $2.9 million by an undisclosed buyer, as of May 23, 2017. Flotek’s current pro-forma debt is approximately $27 million, reduced from a balance of $49.7 million at first quarter’s end.

      John Chisholm, Flotek’s Chairman, President and Chief Executive Officer commented, “We would like to thank our employees, the acquiring Companies, our business partners and all those who worked to arrive at this point in Flotek’s transformation. Our liquidity and cash flow profile have materially improved, allowing financial flexibility to reduce outstanding debt, but also provide Flotek with the ability to execute on growth opportunities. Given ongoing initiatives to further reduce overhead costs and our positioning as a returns-focused and streamlined, chemistry-technology Company, I am confident that we have never been in as strong a position as we are today.”
      3 Antworten
      Avatar
      schrieb am 20.05.18 09:13:14
      Beitrag Nr. 39 ()
      Antwort auf Beitrag Nr.: 55.010.205 von R-BgO am 24.05.17 16:46:38
      dem Kurs hats nicht geholfen,
      dem EK ein bisschen;

      weiter Verlust
      Avatar
      schrieb am 11.01.19 13:10:33
      Beitrag Nr. 40 ()
      Antwort auf Beitrag Nr.: 55.010.205 von R-BgO am 24.05.17 16:46:38
      Flotek Industries To Sell Florida Chemical To ADM For 5 Million

      Enters into Long-Term Reciprocal Agreements and Technical Initiatives to Support and Grow Core Energy Business

      HOUSTON – JANUARY 11, 2019:

      Flotek Industries, Inc. (NYSE: FTK) (“Flotek”) today announced it has entered into a definitive agreement to sell Florida Chemical Company, LLC (“FCC” or “Florida Chemical”), its Consumer and Industrial Chemistry Technologies segment, to Archer Daniels Midland Company (NYSE: ADM) (“ADM”) for total consideration of $175 million in cash, subject to post-closing working capital and other adjustments. With this transaction, Flotek has established itself as a leading specialty chemistry provider of custom, full-fluid solutions to the upstream oil and gas industry. Flotek will retain all of its patents.

      In connection with the sale of FCC, Flotek and ADM have entered into long-term reciprocal supply agreements. The first will secure Flotek’s long-term supply of d-limonene. Additionally, Flotek will manufacture differentiated chemistries for Florida Chemical’s industrial customers. Finally, the companies will explore opportunities to jointly develop next-generation chemistry technologies for the oil and gas and agricultural industries.

      The closing of the transaction is expected during the first quarter of 2019 and is subject to customary closing conditions, including obtaining necessary approval related to the Hart-Scott-Rodino Act. Flotek anticipates that the transaction will have a negligible cash tax effect, as the gain on this sale should be substantially offset by the Company’s outstanding net operating losses.

      John Chisholm, Flotek’s Chairman, President and Chief Executive Officer, commented, “We believe the benefits of this transaction are extremely compelling on multiple fronts and in the best interest of our stakeholders. This transaction unlocks significant value for our stakeholders, while maintaining our access to key raw materials for our Energy Chemistry Technologies (“ECT”) business. The transaction also enhances our flexibility to evaluate and pursue the long-term strategy for our core ECT business. Additionally, we are very excited about our long-term relationship with ADM to develop unique opportunities to more fully leverage their vast, high-performing portfolio of products to better serve the oil and gas market for many years to come. This transaction has created a synergistic relationship that brings strategic benefits to each company and our stakeholders.”

      Vince Macciocchi, President of ADM’s Nutrition business unit, commented, “ADM is already a leader in natural flavors for food and beverages, offering a wide variety of high-value products and solutions in areas such as vanilla and mint, and this acquisition will place us in a leadership position for citrus flavors as well. Citrus is one of the fastest-growing flavor categories, and the single most important taste profile for beverages, and no one in North America does citrus better than Florida Chemical Company.”

      In 2013, Flotek acquired Florida Chemical to vertically integrate its supply of citrus oils, a key raw material in its patented Complex nano-Fluid® (“CnF®”) suite of technologies. Since the original acquisition, the Company’s Energy Chemistry Technologies segment has benefitted from FCC, which enabled Flotek to better manage feedstock costs through the energy downturn from 2014 to 2016, pursue a new go-to-market strategy, and mitigate raw material price inflation caused by citrus greening disease and a significantly limited supply of global citrus oils. Simultaneously, Florida Chemical has expanded its client base and product offerings, while enhancing its processing and distillation capabilities and leveraging its world-class supply chain and highly respected employee base to penetrate into food and beverage applications. This divestiture is the natural next step in Flotek’s evolution, capturing the value of FCC while securing the supply of feedstock required to create the Company’s patented chemistries.

      “ADM is a world-class leader in transforming crops into agricultural and food products. Recognized for its industry-leading capabilities and assets, Florida Chemical will be a significant strategic addition to ADM as they further expand their industry-leading flavor and fragrance offerings. We thank the Florida Chemical team for their invaluable contributions and look forward to continuing our strong relationship moving forward,” said Chisholm.


      ECT Outlook and Related Initiatives

      Following closing of the transaction, Flotek will focus its efforts on providing its global clients best-in-class solutions designed to maximize performance of their oil and gas wells, while simultaneously lowering well costs and fluid complexity. Flotek intends to use the net proceeds to pay off its credit facility balance of approximately $50 million. In addition, the Company is currently considering investing $20 million to $30 million in previously identified organic growth capital projects and will carefully review other future potential uses of the remaining funds.

      Flotek intends to establish a Strategic Capital Committee (the “Committee”) to evaluate and make recommendations to the Board regarding the manner in which the Company will deploy the remaining net proceeds from the sale of FCC. This includes the potential for additional investments in its business, returning capital to shareholders and other potential alternatives. The Committee plans to engage a leading advisory firm.

      Chisholm concluded, “I look forward to a thorough review by our Strategic Capital Committee concerning the best use of the remaining net proceeds from the transaction and updating shareholders as to the results of that process. In addition, we look forward to continuing to benefit from Florida Chemical’s citrus products through our long-term supply agreement with ADM. Finally, we are excited to partner with ADM as we seek new opportunities to expand our offerings to the oil and gas industry.”
      1 Antwort
      Avatar
      schrieb am 11.01.19 18:26:34
      Beitrag Nr. 41 ()
      Damit hat man sein Kerngeschäft ja eigentlich endgültig verscherbelt. Mal sehen, wie es hier weiter geht.
      Avatar
      schrieb am 04.09.19 15:05:14
      Beitrag Nr. 42 ()
      Antwort auf Beitrag Nr.: 59.609.657 von R-BgO am 11.01.19 13:10:33
      Flotek Industries | 1,825 €


      Beitrag zu dieser Diskussion schreiben


      Zu dieser Diskussion können keine Beiträge mehr verfasst werden, da der letzte Beitrag vor mehr als zwei Jahren verfasst wurde und die Diskussion daraufhin archiviert wurde.
      Bitte wenden Sie sich an feedback@wallstreet-online.de und erfragen Sie die Reaktivierung der Diskussion oder starten Sie
      hier
      eine neue Diskussion.

      Investoren beobachten auch:

      WertpapierPerf. %
      -0,47
      -0,76
      +0,27
      +2,58
      +0,10
      +1,03
      -14,04
      +0,76
      -0,71
      +1,29

      Meistdiskutiert

      WertpapierBeiträge
      106
      80
      51
      48
      47
      34
      33
      28
      26
      26
      Flotek Industries - Fracking Zulieferer